ZBH

Zimmer Biomet Holdings, Inc.

Healthcare · $17.2B market cap

Verdict

Share price

$88.29

close of Oct 3, 2026

Fair value

$120.42

Sticker Price

Payback Price

$48.17

buy price

Undervalued

ZBH is Undervalued: at $88.29 it trades 27% below its fair value of $120.42. Its buy price (Payback Price) is $48.17, 45% below today's price. Business quality is limited: none of the 5 key numbers clears the 10% bar.

How we valued it

Owner Earnings. Earnings have been shrinking, but the business still generates cash, so we value it on its cash flow instead of its earnings.

Business quality

0 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth-0.5% a year✗
Equity per share growth6.7% a year✗
Sales growth4.4% a year✗
Free cash flow growth2.9% a year✗
Return on invested capital5.8%✗

Follow ZBH

Get notified when it reaches its buy price of $48.17. Free.

Create a free account

Superinvestors

7 of the investors we track hold ZBH. In Q2 2026, 2 trimmed. Who we track

Moves in Q2 2026

Trimmed: Mairs & Power Funds, Harry Burn

Insider activity

Since Jun 30, 2026: no open-market purchases, 1 sale worth $295K and 10 other filings (stock awards, tax withholding and similar). Why purchases matter

Sales

Other filings

About Zimmer Biomet Holdings, Inc.

Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and…

Medical - Devices

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works